| Literature DB >> 29995952 |
Carlos Balsalobre-Fernández1,2, Blanca Romero-Moraleda2,3, Rocío Cupeiro2, Ana Belén Peinado2, Javier Butragueño2, Pedro J Benito2.
Abstract
PURPOSE: Nitrate-rich beetroot juice supplementation has been extensively used to increase exercise economy in different populations. However, its use in elite distance runners, and its potential effects on biomechanical aspects of running have not been properly investigated. This study aims to analyze the potential effects of 15 days of beetroot juice supplementation on physiological, psychological and biomechanical variables in elite runners.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29995952 PMCID: PMC6040767 DOI: 10.1371/journal.pone.0200517
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the participants.
Personal bests are expressed as range.
| Age (yrs.) | Height (cm) | Weight (kg) | VO2Max (ml*kg-1*min-1) | PB in urban 10 km (min:s) | PB in outdoor 1500m (min:s) | |
|---|---|---|---|---|---|---|
| Experimental group | 27.3±7.8 | 1.79±0.07 | 69.2±8.6 | 69.1±5.3 | 29:22–31:00 | 3:32–3:45 |
| Control group | 24.2±2.9 | 1.78±0.04 | 65.2±2.6 | 72.3±6.8 | 28:28–30:54 | 3:43–3:45 |
Fig 1CONSORT flowchart.
Fig 2Forest plot with standardized mean differences (SMD) and 90% confidence interval (CI) for the rate of perceived exertion (RPE) and oxygen saturation (SmO2) at different running paces.
Lower scores (i.e., to the left in the X-axis) means lower scores in the experimental group.
Mean values and standard deviations for the experimental and placebo groups before (Pre) and after (Post) the supplementation period.
| Experimental group | Placebo group | |||
|---|---|---|---|---|
| Pre | Post | Pre | Post | |
| Leg stiffness (kN/m) | ||||
| 7.9 ± 0.9 | 8.6 ± 1.4 | 8.4 ± 1.2 | 8.5 ± 1.4 | |
| 8.5 ± 1.2 | 8.7 ± 1.2 | 7.9 ± 1.1 | 8.3 ± 1.3 | |
| 8.9 ± 0.8 | 9.2 ± 1.3 | 7.5 ± 1.0 | 8.1 ± 0.8 | |
| RE (ml*kg*min-1) | ||||
| 50.8 ± 3.5 | 52.6 ± 2.8 | 52.3 ± 3.3 | 53.7 ± 3.8 | |
| 58.3 ± 2.7 | 60.4 ± 2.3 | 60.1 ± 3.8 | 62.1 ± 3.3 | |
| 67.3 ± 4.4 | 69.5 ± 2.9 | 70.5 ± 5.1 | 71.4 ± 4.8 | |
| RER | ||||
| 0.87 ± 0.02 | 0.83 ± 0.02 | 0.91 ± 0.02 | 0.87 ± 0.01 | |
| 0.93 ± 0.02 | 0.90 ± 0.03 | 0.96 ± 0.02 | 0.94 ± 0.02 | |
| 1.03 ± 0.01 | 0.97 ± 0.04 | 1.07 ± 0.03 | 1.03 ± 0.03 | |
| HR (bpm) | ||||
| 147.2 ± 13.7 | 146.9 ± 11.2 | 157.3 ± 10.0 | 151.4 ± 12.4 | |
| 160.6 ± 12.2 | 157.3 ± 9.2 | 168.1 ± 8.1 | 165.9 ± 7.1 | |
| 164.2 ± 19.1 | 168.4 ± 11.4 | 164.6 ± 21.1 | 177.1 ± 4.6 | |
| SmO2 (%) | ||||
| 41.7 ± 7.1 | 47.7 ± 3.9 | 46.6 ± 15.5 | 43.7 ± 5.9 | |
| 34.4 ± 3.5 | 41.0 ± 2.0 | 38.2 ± 16.4 | 37.8 ± 5.2 | |
| 24.4 ± 2.8 | 31.0 ± 6.9 | 26.8 ± 12.1 | 27.7 ± 4.8 | |
| TEx (s) | 1173.0 ± 87.1 | 1269.0 ± 53.6 | 1251.0 ± 52.6 | 1230 ± 73.5 |
| VO2Max (ml*kg*min-1) | 69.1 ± 5.3 | 70.1 ± 7.0 | 72.3 ± 6.8 | 74.9 ± 6.1 |
| RPE | ||||
| 2.4 ± 0.5 | 2.3 ± 0.5 | 2.4 ± 0.5 | 3.5 ± 0.8 | |
| 3.8 ± 0.8 | 4.0 ± 0.8 | 4.4 ± 0.5 | 5.6 ± 0.8 | |
| 6.0 ± 0.7 | 6.0 ± 1.0 | 7.2 ± 0.4 | 7.7 ± 1.0 | |
Abbreviations: RE = running economy; VO2Max = maximal oxygen consumption; RER = respiratory exchange ratio; TEx = time to exhaustion; HR = heart rate; SmO2 = saturation of muscle O2; RPE = rate of perceived exertion
Pre-post differences on the studied variables in the placebo vs experimental conditions.
| SMD (90%CI) | Chances of being beneficial/trivial/harmful | Qualitative inference | % of change (experimental vs placebo) | P | |
|---|---|---|---|---|---|
| Leg stiffness | -0.14 (-0.44, 0.17) | 4/61/36 | Possibly | 2.25 vs 4.64 | 0.310 |
| RE | 0.36 (-0.5, 1.21) | 63/24/13 | Unclear | 7.07 vs 4.5 | 0.589 |
| VO2Max | 0.04 (-0.87, 0.95) | 37/31/32 | Unclear | 4.41 vs. 3.66 | 1.000 |
| Av_RER | -0.2 (-1.15, 0.74) | 50/27/22 | Unclear | -4.7 vs. -3.6 | 1.000 |
| TEx (s) | 1.18 (-0.14, 2.5) | 90/6/4 | Likely | 8.18 vs 1.6 | 0.310 |
| Av_HR | 0.03 (-0.36, 0.42) | 22/64/15 | Unclear | -0.26 vs. 1.14 | 0.792 |
| SmO2 | 0.72 (0.03, 1.41) | 91/7/2 | Likely | 17.8 vs. -2.64 | 0.167 |
| RPE | -2.17 (-3.23, -1.1) | 100/0/0 | Very likely | -9.0 vs 20.4 | 0.016 |
Standardized mean differences (SMD) with 90% Confidence Intervals (CI) express the magnitude of the difference on the pre-post changes between the experimental and placebo groups. Positive values reflect higher increments on the placebo group after the supplementation period, while negative scores reflect lower increments on the experimental group after the supplementation period. P is the asymptotic significance of the Mann-Whiteny’s U test.
Abbreviations: RE = running economy; VO2Max = maximal oxygen consumption; Av_RER = average respiratory exchange ratio (whole test); TEx = time to exhaustion; Av_HR = average heart rate (whole test); SmO2 = saturation of muscle O2; RPE = rate of perceived exertion